IP Library Assignment 032971/0193
Patent Assignment
Reel/Frame 032971/0193

Confirmatory License

Recorded: 2014-05-21 Pages: 2
Assignor
ARMAGEN TECHNOLOGIES, INC.
Executed: 2014-05-06
Assignee
NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
NIH DIVISION OF EXTRAMURAL INVENTIONS AND TECHNOLOGY RESOURCES (DEITR), 6705 ROCKLEDGE DRIVE, SUITE 310, MSC 7980, BETHESDA, MARYLAND, 20892-7980
Covered Property (1)
Fusion Antibodies That Cross the Blood-Brain Barrier in Both Directions
Patent: 7,741,446 →
Application: 11/841,623 →
Publication: US US20080170994A1
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 16, 2008
From: PARDRIDGE, WILLIAM M.; BOADO, RUBEN J.
To: ARMAGEN TECHNOLOGIES, INC.
Reel/Frame 020370/0760 →
Security Interest Feb 2, 2018
From: ARMAGEN, INC.
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT AND LENDER
Reel/Frame 044815/0135 →
Assignment of Assignor's Interest Nov 18, 2019
From: OXFORD FINANCE LLC
To: JCR PHARMACEUTICALS CO., LTD.
Reel/Frame 051042/0528 →
Release of Security Interest Apr 11, 2020
From: JCR PHARMACEUTICALS CO., LTD.
To: ARMAGEN, INC.
Reel/Frame 052373/0585 →